These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 227624)

  • 41. [Vitamin E megadoses and their effect on HDL cholesterol levels in patients with atherosclerotic complications (author's transl)].
    Turay J; Beseda I; Michalcová A
    Cas Lek Cesk; 1981 Dec; 120(48):1432-4. PubMed ID: 6947861
    [No Abstract]   [Full Text] [Related]  

  • 42. Lipoproteins and cholesterol esterification rate in men and women with hypercholesterolaemia of type IIa.
    Moberg B; Wallentin L
    Scand J Clin Lab Invest; 1981 Nov; 41(7):655-61. PubMed ID: 7339867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
    Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux.
    Guerin M; Le Goff W; Frisdal E; Schneider S; Milosavljevic D; Bruckert E; Chapman MJ
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3738-46. PubMed ID: 12915663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies in asymptomatic primary hyperlipidaemia. IV. ECG at rest and during exercise and its relation to various lipoprotein classes.
    Olsson AG; Ekelund LG; Carlson LA
    Acta Med Scand; 1975; 198(1-2):55-73. PubMed ID: 170796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of a no-sugar diet on the composition of VLDL-fraction in patients with idiopathic hyperlipoprotenemia of type IIb and IV.
    Cybulska B; Naruszewicz M; Kłosiewicz-Latoszek L; Szostak WB; Chotkowska E
    Mater Med Pol; 1980; 12(4):286-92. PubMed ID: 7266054
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of beta-pyridylcarbinol on lipoprotein lipids in primary type IIa hyperlipoproteinemia.
    Schwandt P; Weisweiler P; Neureuther G
    Atherosclerosis; 1979 Sep; 34(1):35-9. PubMed ID: 227427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemical composition of ultracentrifugal fractions in different patterns of human atheroslcerosis.
    Avogaro P; Cazzolato G; Taroni GC; Belussi F
    Atherosclerosis; 1977 Feb; 26(2):163-72. PubMed ID: 189783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum lipoprotein pattern after SAMe-treatment.
    Rini GB; Di Fede G; Rotolo G; Rizzo G; Mascellino MR; Affronti M; Delle Vedove G
    Boll Soc Ital Biol Sper; 1987 Oct; 63(10):919-22. PubMed ID: 3447603
    [No Abstract]   [Full Text] [Related]  

  • 51. The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia.
    Dachet C; Jacotot B; Buxtorf JC
    Atherosclerosis; 1985 Dec; 58(1-3):261-8. PubMed ID: 4091882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
    Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
    Vessby B; Hedstrand H; Olsson U
    Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of D-thyroxine on lipoprotein lipids and apolipoproteins in primary type IIa hyperlipoproteinemia.
    Schwandt P; Weisweiler P
    Atherosclerosis; 1980 Mar; 35(3):301-6. PubMed ID: 6987993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of plasma total cholesterol as a test to detect elevated low density (beta) lipoprotein cholesterol levels (type IIa hyperlipoproteinemia) in young subjects from a population-based sample.
    Kwiterovich PO; Heiss G; Johnson N; Chase GA; Tamir I; Rifkind B
    Am J Epidemiol; 1982 Feb; 115(2):192-204. PubMed ID: 7058778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pre- and post-treatment values of HDL cholesterol and total: HDL cholesterol ratio in hyperlipoproteinaemic subjects.
    Sale JK; Johnstone JH
    Ann Clin Biochem; 1981 Mar; 18 (Pt 2)():71-5. PubMed ID: 7259072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Serum lipids levels, lipoprotein phenotypes and analysis of lipoprotein in Italian population group (author's transl)].
    Avogaro P; Cazzolato G; Capri C; Pais M; Trabuio GF
    G Ital Cardiol; 1974; 4(2):237-48. PubMed ID: 4365662
    [No Abstract]   [Full Text] [Related]  

  • 58. Vitamin E and lipoproteins in hyperlipoproteinemia.
    Lambert D; Mourot J
    Atherosclerosis; 1984 Dec; 53(3):327-30. PubMed ID: 6529449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Dietary treatment of patients with familial hyperlipoproteinemias].
    Solovév EIu; Rozhkova TA; Koshechkin VA; Pogozhaeva AV
    Kardiologiia; 1992; 32(11-12):56-8. PubMed ID: 1297883
    [No Abstract]   [Full Text] [Related]  

  • 60. Lack of effect of ascorbic acid on serum lipoprotein concentrations in patients with hypertriglyceridaemia.
    Wahlberg G; Walldius G
    Atherosclerosis; 1982 Jun; 43(2-3):283-8. PubMed ID: 7115465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.